Skip to main content

Table 1 Patient characteristics

From: Plasma levels of leptin and soluble leptin receptor and polymorphisms of leptin gene -18G > A and leptin receptor genes K109R and Q223R, in survivors of childhood acute lymphoblastic leukemia

Feature

Total

CRT

No CRT

 

Number of patients (%)

Total

82 (100)

31(38)

51(62)

Gender:

   

Female

37 (45)

16 (20)

21(26)

Male

45 (55)

15 (18)

30 (36)

ALL status:

   

First complete remission

79 (96)

29 (35)

50 (61)

Relapses

3

2

1

CNS

1

1

0

Testes

2

1

1

BM + CNS

0

0

0

Intensity of protocol:

   

High intensity

14 (17)

13 (16)

1 (1)

Standard intensity

68 (83)

18 (22)

50 (61)

Age at diagnosis(years)

1-16,9

1,9-13,7

1-16,9

Median

4,5

4,2

4,8

Age at study (years)

4,8-26,2

4,8-26,2

5,6-24,2

Median

13,2

17,7

11,4

Time from the start of

0,9-20,7

2,8-20,7

0,9-10,4

ALL treatment (years)

   

Median

7,8

12,7

6,1

Time from completion of ALL treatment (years)

0,5-4,3

1,8-4,3

0,5-3,4

Median

3,2

2,7

3,2

  1. ALL - acute lymphoblastic leukemia; CRT - cranial radiotherapy